Factors | N (bNED rate, %) |
---|---|
PSA | |
0-20.0 ng/ml | 79 (59/76) |
>20.0 ng/ml | 60 (25/42) |
p-value | 0.028 |
Gleason score | |
<7 | 77 (53/69) |
≥7 | 65 (31/48) |
p-value | 0.137 |
Clinical stage | |
T1b-T2b | 78 (52/67) |
T2c | 64 (32/50) |
p-value | 0.094 |
Prostate volume | |
≥30 ml | 74 (40/54) |
<30 ml | 70 (44/63) |
p-value | 0.740 |
PPC | |
<50% | 81 (56/69) |
≥50% | 58 (28/48) |
p-value | 0.006 |
D 90 | |
≥140 Gy | 81 (63/78) |
<140 Gy | 52 (17/33) |
p-value | 0.009 |